HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 29, 2024

Rhea-AI Summary

Harmony Biosciences Holdings (Nasdaq: HRMY) has announced it will report its third quarter 2024 financial results on Tuesday, October 29, 2024, before the U.S. financial markets open. The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results.

To participate in the call, investors can dial (800) 245-3047 (domestic) or (203) 518-9765 (international) and use the passcode HRMYQ324. It is advised to dial in at least 10 minutes before the call starts. A live and replay webcast of the call will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.

PLYMOUTH MEETING, Pa., Oct. 16, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report third quarter 2024 financial results on Tuesday, October 29, 2024, before the open of the U.S. financial markets. Harmony will host a conference call and webcast on October 29, 2024, at 8:30 a.m. ET to discuss the results.

To participate in the call, please dial (800) 245-3047 (domestic) or (203) 518-9765 (international), and reference passcode HRMYQ324. It is recommended that you dial in at least 10 minutes prior to the call.

The live and replay webcast of the call will be available on the investor page of our website at https://ir.harmonybiosciences.com/. 

About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
bdoyle@harmonybiosciences.com

Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-report-third-quarter-2024-financial-results-on-october-29-2024-302277106.html

SOURCE Harmony Biosciences

FAQ

When will Harmony Biosciences (HRMY) report its Q3 2024 financial results?

Harmony Biosciences (HRMY) will report its third quarter 2024 financial results on Tuesday, October 29, 2024, before the U.S. financial markets open.

What time is Harmony Biosciences' (HRMY) Q3 2024 earnings call scheduled for?

Harmony Biosciences' (HRMY) Q3 2024 earnings conference call and webcast is scheduled for October 29, 2024, at 8:30 a.m. ET.

How can investors participate in Harmony Biosciences' (HRMY) Q3 2024 earnings call?

Investors can participate in Harmony Biosciences' (HRMY) Q3 2024 earnings call by dialing (800) 245-3047 (domestic) or (203) 518-9765 (international) and using the passcode HRMYQ324.

Where can I find the webcast for Harmony Biosciences' (HRMY) Q3 2024 earnings call?

The live and replay webcast for Harmony Biosciences' (HRMY) Q3 2024 earnings call will be available on the investor page of the company's website at https://ir.harmonybiosciences.com/.